New AI tool ‘TORCH’ successfully identifies cancer origins in unknown primary cases
Researchers developed the TORCH deep-learning approach to differentiate tumor origins using cytological histology pictures from over 57,000 patients with hydrothorax and ascites. The AI model showed high accuracy in predicting…
Hate Taking Pills? For Some Drugs, You Won’t Need To
Buccal patches stuck to the inside of the mouth offer a quicker and potentially side effect-free way to deliver drugs, especially for those who struggle with swallowing pills or insulin…
Hospice Handoffs May Lower Odds of Medicare Denials
Better communication between primary care clinicians and hospice providers can reduce the number of denied Medicare approvals for end-of-life treatment. Dr. Tyler Haussler conducted a study showing that poor documentation…
Build Your Dream Skincare Regimen
Korean sunscreens are revolutionizing sun care by offering innovative formulas that go beyond basic sunblock to provide multiple skincare benefits. These sunscreens have cutting-edge formulations, lightweight textures, and high levels…
Non-thermal atmospheric-pressure plasma novel approach to treatment of bone fractures: Study
A recent study explores the use of non-thermal atmospheric-pressure plasma as a novel approach for treating bone fractures. This method shows promise in promoting bone healing and regeneration. The study…
Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform
Ilant Health, a virtual obesity management company, extended its seed funding round from $3 million to $5.5 million. Based in New York City, the company provides value-based care to employers…
Dr Anthony Fauci receives honours on Irish visit
In a special ceremony, renowned immunologist Dr. Anthony Fauci was awarded an honorary fellowship by the UCD School of Medicine and received the Fulbright Ireland Public Service Award for his…
In San Francisco’s Chinatown, a CEO Works With the Community To Bolster Hospital
Chinese Hospital in San Francisco, located in Chinatown, faces financial challenges common in underserved areas. Many patients are elderly with limited incomes and rely on Medicare and Medi-Cal. The hospital…
Takeda’s Entyvio snags second FDA approval as ‘subcutaneous option’ for Crohn’s disease
The FDA has approved the subcutaneous administration of Takeda Pharmaceuticals' Entyvio for maintenance therapy in adult patients with moderate-to-severe Crohn’s disease after induction therapy via IV administration. The approval was…
STAT+: Up and down the ladder: The latest comings and goings
Share your new hires, promotions, and job changes with us so we can share them with others. This week, Athira Pharma hired Javier San Martin as chief medical officer, previously…